Completed PHASE1 INTERVENTIONAL 3-arm NCT01864876

The Effects of GLA (5 mcg) on Human Volunteers

A Randomized, Single-Blinded Phase 1 Study to Evaluate the Safety and Immunogenicity of a Single Administration of 5 mcg GLA in Healthy Volunteers

Sponsor: Access to Advanced Health Institute (AAHI)

Conditions Healthy Volunteers

Interventions EM060G (SE) GLA-AF GLA-SE

Updated 7 times since 2017 Last updated: Feb 24, 2014 Started: Sep 30, 2012 Primary completion: Dec 31, 2013 Completion: Dec 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Healthy Volunteers, this trial is completed. The trial is conducted by Access to Advanced Health Institute (AAHI) and has accumulated 7 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jun 2023 — Jul 2024 [monthly]

Completed PHASE1
Jan 2021 — Jun 2023 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed PHASE1
Jan 2017 — Feb 2017 [monthly]

Completed PHASE1

First recorded

Sep 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Access to Advanced Health Institute (AAHI)
Rockefeller University

Data source: Access to Advanced Health Institute (AAHI)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States